Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/12/2017
SIETES contiene 92150 citas

 
 
 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Engel P, Almas MF, De Bruin ML, Starzyk K, Blackburn S, Dreyer AN. Lessons learned on the design and the conduct of Post-Authorization Safety Studies: review of 3 years of PRAC oversight. Br J Clin Pharmacol 2017;83:884-93. [Ref.ID 101970]
2.Enlace a cita original Cita con resumen
Bouvy JC, Blake K, Slattery J, De Bruin ML, Arlett P, Kurz X. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005–2013. Pharmacoepidemiol Drug Saf 2017:26 de marzo. [Ref.ID 101903]
3.Enlace a cita original Cita con resumen
Bouvy JC, Huinink L, De Bruin ML. Benefit-risk reassessment of medicines: a retrospective analysis of all safety-related referral procedures in Europe during 2001–2012. Pharmacoepidemiol Drug Saf 2016;25:1004-14. [Ref.ID 100902]
4.Enlace a cita original
Goossens ME, Buntinx F, Zeegers MP, Driessen JHM, De Bruin ML, de Vries F. Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol 2015;80:1464-72. [Ref.ID 99779]
5. Cita con resumen
Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf 2015;38:437-53. [Ref.ID 99237]
6. Cita con resumen
Duijnhoven RG, Straus SMJM, Raine JM, de Boer A, Hoes AW, De Bruin ML. Number of patients studied prior to approval of new medicines: database analysis. PLOS Medicine 2013;10:1. [Ref.ID 95146]
7.
Stefansdottir G, De Bruin ML, Knol MJ, Grobbee DE, Leufkens HGM. Randomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety. Drug Saf 2011;34:783-92. [Ref.ID 91038]
8.
De Bruin ML, Langendijk PNJ, Koopmans RP, Wilde AAM, Leufkens HGM, Hoes AW. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2007;63:216-23. [Ref.ID 79126]
9. Cita con resumen
De Bruin ML, van Puijenbroek EP, Egberts ACG, Hoes AW, Leufkens HGM. Non-sedating antihistamine drugs and cardiac arrhythmias - biased risk estimates from spontaneous reporting systems?. Br J Clin Pharmacol 2002;53:370-4. [Ref.ID 61563]
Seleccionar todas
 
 1 a 9 de 9